We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Biologic Hydrogel Helps Brain Tissue Regenerate After Injury

By HospiMedica International staff writers
Posted on 15 Sep 2009
An injectable gel made of a combination of synthetic and natural sources may help brain tissue grow at the site of a traumatic brain injury (TBI), claims a new study.

The novel biomaterial, developed by a researcher from Clemson University (SC, USA), has the potential to spur the growth of a patient's own neural stem cells, structurally repairing the brain injury site. More...
The new gel could treat patients at varying stages following injury, and it is expected to be ready for testing in humans in about three years. Besides delivery of stem cells, the hydrogel can also be loaded with a range of different chemicals to stimulate various other biologic processes (such as reestablishing a full blood supply at the injury site), thus potentially providing a much friendlier environment for the donor cells to thrive. In a laboratory trial, eight weeks after treatment with the hydrogel, rats with severe TBI showed signs of making a significant recovery. The study describing the trial was presented at the U.S. Military Research Forum, held during September 2009 in Kansas City (MO, USA).

"We have seen an increase in brain injuries due to combat, but our strategy can also potentially be applied to head injuries caused by car accidents, falls, and gunshot wounds,” said study presenter assistant professor of bioengineering Ning Zhang, Ph.D. "These results that we are seeing in adult lab rats are the first of its kind and show a sustained functional recovery in the animal model of TBI. It also represents one of very few in the traumatic brain injury field that attempts structural repair of the lesion cavity using a tissue-engineering approach.”

Dr. Zhang added that current approaches to TBI have been focused on managing the primary injury using hypothermia or neuro-protection with pharmacologic agents, all with limited success. In previous laboratory studies, Dr. Zhang has already demonstrated the reconstruction of a complete vascular network at the injury site as an initial step toward brain tissue regeneration.

Related Links:
Clemson University


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Endoscopy Display
E190
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.